Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate.
read more
Thursday, January 22, 2015
The Pharma & Biopharma Outsourcing Association (PBOA) today announced that Nelson Patterson, Vice President, Sales and Marketing at Baxter BioPharma Solutions, has been elected to its Board of Trustees, effective immediately. Mr. Patterson was ...
read more
Baxter International announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company.
read more
Baxter announced receipt of a major R&D grant from the German BMBF’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free HD option for ESRD.
read more
Baxter announced an agreement to acquire two hemostat and sealant products from Mallinckrodt: RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant.
read more
Baxter and the International Society of Nephrology announced a partnership to advance CKD awareness and help improve access to therapy, particularly in LMIC where the disease prevalence is growing the fastest.
read more
Wednesday, March 10, 2021
Baxter Moderna have entered into an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.
read more
Bay Area Research Logistics (BARL), a clinical trial services company announced its physical expansion into the US market with the opening of a new depot in New York State. BARL has been providing clinical supply services since 2007 for all phases of...
read more
Wednesday, October 28, 2020
Bayer AG and Asklepios BioPharmaceutical (AskBio) announced an agreement under which Bayer will acquire AskBio.
read more
Bayer will fully acquire BlueRock Therapeutics, a biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology and immunology.
read more
Bayer announced the appointment of Bhavesh Ashar as senior vice president and head of Oncology for the company's Pharmaceuticals Division in the United States.
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases.
read more
Tuesday, November 14, 2017
Bayer has entered into an exclusive global collaboration with Loxo Oncology for the development and commercialization of larotrectinib.
read more
Wednesday, September 13, 2017
BC Platforms has launched BC|RQUEST, a resource that enables integrated analytics of genomic and clinical data.
read more
Monday, December 23, 2019
BC Platforms has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™.
read more